Back to Pictet Asset Management Holding SA Pictet Asset Management Holding SA

CLDXCLDX
12 quarters

Position history for Pictet Asset Management Holding SAPictet Asset Management Holding SA's holdings in Celldex Therapeutics, Inc.

Pictet Asset Management Holding SA holds 917,408 shares of CLDX (Celldex Therapeutics, Inc.), worth $34.1M as of 2026-Q2. The position was decreased (-0.7% shares). CLDX represents 0.0% of Pictet Asset Management Holding SA's portfolio.

Current Value

$34.1M

Current Shares

917,408

Total Value Change

-$16.8M

Total Shares Change

-933,562

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
917,408
-0.7%
$34.1M0.0%$37.21
0
2026-Q1
Decreased
923,696
-4.6%
$29.3M0.0%$28.94
0
2025-Q4
Decreased
968,616
-20.1%
$26.3M0.0%$26.43
0
2025-Q3
Decreased
1.2M
-6.8%
$31.4M0.0%$26.19
0
2025-Q2
Increased
1.3M
+35.8%
$26.5M0.0%$20.29
37
2025-Q1
Decreased
957,794
-12.1%
$17.4M0.0%$19.93
0
2024-Q4
Decreased
1.1M
-4.2%
$27.5M0.0%$25.12
0
2024-Q3
Decreased
1.1M
-17.7%
$38.7M0.0%$33.20
0
2024-Q2
Decreased
1.4M
-7.4%
$51.2M0.1%$37.01
0
2024-Q1
Decreased
1.5M
-32.8%
$62.7M0.1%$41.97
0
2023-Q4
Increased
2.2M
+20.2%
$88.3M0.1%$39.66
35
2023-Q3
New
1.9M
-
$50.9M0.1%$27.52
41

Other major holders of CLDX: BNP PARIBAS FINANCIAL MARKETS, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used